Methodology

All entries for: Delnaggar Biotech Group

January 5, 2026

Delnaggar Biotech Group

Orphan Drug Designation

FDA orphan drug designation: treatment of high-grade anal intraepithelial neoplasia (HGAIN)

Disease Area: Rare Diseases
Source
Source
December 9, 2025

Delnaggar Biotech Group

Orphan Drug Designation

FDA orphan drug designation: treatment of high-grade anal intraepithelial neoplasia

Disease Area: Rare Diseases
Source
Source
December 9, 2025

Delnaggar Biotech Group

Orphan Drug Designation

FDA orphan drug designation: treatment of high-grade anal intraepithelial neoplasia

Disease Area: Rare Diseases
Source
Source
Scroll to Top